Ask Warren

Vaxcell-Bio Therapeutics

323990 · KOSDAQ · ₩323990 · 박셀바이오

₩3,790▼ ₩165 (4.17%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

20252024202320222021
Revenue₩7.1B₩1.9B₩14M——
Cost of sales₩6.2B₩1.5B₩6.6M——
Gross profit₩893M₩365M₩7.1M——
Operating income−₩15B−₩15B−₩12B−₩8.2B−₩5.9B
Net income−₩13B−₩11B−₩10B−₩6.8B−₩4.8B
Net income to shareholders−₩13B−₩11B−₩10B−₩6.8B−₩4.8B

Balance sheet

20252024202320222021
Total assets₩67B₩77B₩85B₩24B₩31B
Current assets₩30B₩39B₩51B₩21B₩28B
Cash and equivalents₩6.2B₩7.8B₩9B₩390M₩2.3B
Total liabilities₩5.8B₩4.9B₩1.5B₩836M₩1.2B
Current liabilities₩3.5B₩2.8B₩924M₩307M₩392M
Borrowings₩1.8B₩1.2B₩630M₩177M₩160M
Total equity₩61B₩72B₩83B₩23B₩30B
Shareholders' equity₩61B₩72B₩83B₩23B₩30B

Cash flow

20252024202320222021
Cash from operations−₩11B−₩11B−₩9.4B−₩6B−₩4.7B
Capital spending₩6B₩2.1B−₩166M−₩167M₩2.1B
Free cash flow−₩17B−₩13B−₩9.6B−₩6.2B−₩6.8B

Consolidated where available. Amounts in won.

Also known as: Vaxcell-Bio Therapeutics / 박셀바이오 / 323990 / KRX:323990

Source: KRX statistical information